This study supports the hypothesis that GLP-1 receptor agonists may reduce the symptom burden in fibromyalgia patients, particularly with regard to opioid dependency, fatigue and pain, wrote Nouran Eshak, MB, ChB, rheumatology fellow at Mayo Clinic and the lead investigator of the study
Therefore, further screening with ApoB to measure particle number is not so much about diagnosing people but really about finding that subset of patients who might need more medication and more aggressive treatment to lower their cholesterol even further
Side effects do not directly mean muscle loss is happening, but nausea, constipation, fatigue, reflux, and low appetite can make it harder to eat enough protein and maintain resistance training
& Engelsen, B
The answer is no, and attempting to do so typically costs more in the long run
J Control Release (2022) 348:37085